Tom Snyder Email and Phone Number
Tom Snyder work email
- Valid
- Valid
- Valid
- Valid
Tom Snyder personal email
- Valid
Tom Snyder phone numbers
Global and US Market Access leader with experience launching first-in-class brands. At Amgen and BMS, I led strategic planning for US payer initiatives for products in pharmacy (specialty and retail), medical (including buy-and-bill clinic and hospital), and device/durable medical channels. In US Value & Access, I have led strategic initiatives focused on PBM business models; co-authored a white paper on PBM economics and gross-to-net; and led opportunities for pharmacy benefit biosimilars with entities across the supply chain. These experiences built upon my foundation in medical benefit and provider reimbursement, which I developed through consulting in multiple therapeutic areas including rare disease, and launching anti-PD1 OPDIVO and EVENITY. As a leader, I am known for my ability to navigate complex organizations and optimize pipeline and portfolio value working across Global to US, and vice versa. Outside the US (Europe & Asia), I have secured access for innovative medicines approved under accelerated timelines, by leveraging real-world evidence, innovative financing, and payer engagement.
-
Executive Director, Us Value And Access | Obesity And PipelineAmgenLos Angeles, Ca, Us -
Executive Director, Us Value & Access - Obesity And PipelineAmgen Jul 2024 - PresentThousand Oaks, Ca, Us
-
Strategic Planning And Operations | Us Value & AccessAmgen Aug 2022 - Jul 2024Thousand Oaks, Ca, UsAs leadership development assignment, serving as Chief of Staff for VP of US Value & Access (~250 FTEs). Responsible for day-to-day operations and capability builds (budget, headcount & talent, training & development, process excellence), strategic planning including long range scenarios, and program management. Since joining, managed several strategic portfolio initiatives (Inflation Reduction Act scenario planning, Gross to Net transformation, pricing corporate narrative and external engagement, biosimilar launches, pipeline planning).
-
Executive Director And Therapeutic Area Head-Oncology Value & AccessAmgen May 2021 - Aug 2022Thousand Oaks, Ca, UsLeading Global Value & Access Strategy for pipeline and launches including LUMAKRAS (KRAS G12C). Interim VP of Global Value & Access in 1H 2021 (150 staff in Access, Pricing, Health Economics, and Policy).
-
Executive Director And Therapeutic Area Head-Solid Tumor Oncology Value & AccessAmgen May 2019 - May 2021Thousand Oaks, Ca, UsLed Value & Access Strategy for oncology pipeline: LUMAKRAS (KRAS G12C), bemarituzumab (FGFRb2), bispecific T-cell engagers.
-
Director, Global Payer Lead Immuno-OncologyAmgen May 2016 - May 2019Thousand Oaks, Ca, UsGlobal Value & Access lead for Immuno-Oncology and Inflammation, and launch of EVENITY (romosozumab) for post-menopausal osteoporosis.
-
Director, Head Of La OfficeEversana 2015 - 2016Chicago, Il, UsDrove new business development, delivery, and thought leadership for a life sciences consulting firm (Promidian). Created launch plans to prepare biotechs for their first commercial launches of CAR-Ts in the US. -
Director, Access Strategy, Immuno-Oncology (Nivolumab)Bristol-Myers Squibb 2012 - 2015Lawrence Township, Nj, UsLed all access activities supporting launch of anti-PD1 OPDIVO (nivolumab) in non-small cell lung cancer globally, and access strategy and value evidence generation for anti-IL6 in rheumatoid arthritis. -
Senior ConsultantBridgehead International 2011 - 2012Nuremberg, Bavaria, DeDirect global market access strategy engagements, pricing research (payer, physician, and patient), and payer value message development for biotechs and pharmaceutical clients. -
Director, Pricing And Market AccessParexel 2010 - 2011Durham, North Carolina, UsLed US Pricing and Market Access practice. Developed launch plan for a dual-brand biologic in multiple sclerosis and leukemia. Published evidence reviews informing Medicare coverage of EPOGEN and ARANESP. -
Associate Director, Payer Marketing - Wound TherapeuticsConvatec 2009 - 2010London, England, GbLed global marketing strategies and tactics to communicate value proposition of products, portfolio, and services to C-suite decision-makers. -
Associate Director, Us Public Policy & ReimbursementConvatec 2006 - 2009London, England, GbSecured positive coverage, coding, and payment decisions for surgical care products and DME. Developed business plans and value propositions in collaboration with marketing and sales leaders. Led due diligence for licensing and acquisition opportunities. Representative to trade associations and liaison to patient advocacy and lobbying activities.
-
Manager, Health And Life SciencesAccenture 2005 - 2006Dublin 2, IeProvided strategic consulting support for implementation of Part D payment mechanisms; program management for joint medical/marketing initiatives, pharmaceutical/not-for-profit partnerships, and managed markets analytic support; managed analysts and consultants. -
Senior Project ManagerParexel International 2003 - 2005Durham, North Carolina, UsSecured favorable coverage, coding, and payment decisions for client's biopharmaceutical therapies; identified optimal distribution strategies, pricing, sales force training needs, and reimbursement support (hotlines and patient assistance) to support product launches; interacted with CMS and Carrier Medical Directors on behalf of clients; direct reports included Reimbursement and Health Policy Project Managers and analysts.
-
Senior Reimbursement AnalystAmerican Red Cross - Biomedical Services 2002 - 2003Educated CMS on costs of blood products and advanced clinical diagnostics; advocated with CMS for favorable coverage, coding, and payment of blood products, plasma derivative therapies, and transfusion services; educated hospital and blood bank executives on coding, billing, and cost reporting for transfusion medicine services.
-
Senior ConsultantThe Advisory Board Company 1999 - 2002Washington, District Of Columbia, UsConducted best-practice research into hospital operations and service line strategy; managed teams of analysts and consultants.
Tom Snyder Skills
Tom Snyder Education Details
-
University Of MichiganEnglish -
University Of HoustonEnglish
Frequently Asked Questions about Tom Snyder
What company does Tom Snyder work for?
Tom Snyder works for Amgen
What is Tom Snyder's role at the current company?
Tom Snyder's current role is Executive Director, US Value and Access | Obesity and Pipeline.
What is Tom Snyder's email address?
Tom Snyder's email address is th****@****hoo.com
What is Tom Snyder's direct phone number?
Tom Snyder's direct phone number is (781)-235*****
What schools did Tom Snyder attend?
Tom Snyder attended University Of Michigan, University Of Houston.
What skills is Tom Snyder known for?
Tom Snyder has skills like Market Access, Oncology, Health Economics, Pharmaceutical Industry, Medical Devices, Strategy, Immunology, Managed Care, Biopharmaceuticals, Biotechnology, Wound Care, Commercialization.
Who are Tom Snyder's colleagues?
Tom Snyder's colleagues are Michael Green, Jiraporn J., Mitchell Dyer, Michael Charleton, Kalyan C., Zenia Motiwala, Grace M. Fontanez Santana.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial